Peter Staller is the Director and Head of Functional Genomics Research at Nuvisan Pharma Services, a position held since 2020. Previously, they served as the Director of Target Validation Technologies at Bayer HealthCare from 2015. Staller's academic background includes a PhD from Heidelberg University and a MSc in Biochemistry from Leibniz Universität Hannover. They also held postdoctoral research positions at ETH Zurich and the Friedrich Miescher Institute for Biomedical Research, and were an Associate Professor at the University of Copenhagen before leading oncology research at EpiTherapeutics ApS from 2011 to 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices